SCHEMBL6799557

SCHEMBL6799557

Cc1ccc(C(=O)O)c(-c2ccc(Cl)cc2)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
DHODH Q02127 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2A6 P11509 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
AURKA O14965 1/20 0.43
TPX2 Q9ULW0 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TSHR P16473 2/20 0.43
CASP1 P29466 1/20 0.43
KDM4E B2RXH2 2/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28750800 0.85 NPC1 (0.46) NPC1RAB9ADHODHCYP1A2CYP3A4
SCHEMBL6026603 0.84 FABP4 (0.49) NPC1RAB9ACYP1A2CYP3A4CYP2C9
SCHEMBL6801051 0.83 BCL2L1 (0.44) NPC1RAB9ADHODHSMN1; SMN2KDM4E
SCHEMBL6804369 0.79 MYC (0.54) NPC1RAB9ADHODHCYP3A4CYP2C9
SCHEMBL6803603 0.79 RXRB (0.54) DHODHCYP2C8CYP2C19KDM4EHPGD
Hydrochloric Acid SCHEMBL7907584 0.78 MYC (0.53) NPC1RAB9ADHODHCYP3A4CYP2C9
SCHEMBL27517441 0.75 NPC1 (0.54) NPC1RAB9ADHODHAURKATPX2
SCHEMBL10024251 0.75 MCL1 (0.54) NPC1RAB9ACYP2C9AURKATPX2
SCHEMBL10024263 0.75 RXRB (0.58) NPC1RAB9ASMN1; SMN2TSHRCASP1
SCHEMBL7924637 0.74 TSHR (0.47) CYP1A2CYP3A4CYP2C9SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 NPC1 40/4885RAB9A 4004/4885DHODH 4644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.